Molecular Epidemiology of VIM-4 Metallo-β-Lactamase-Producing Pseudomonas sp. Isolates in Hungary-Reference-Cited by-同舟云学术

Molecular Epidemiology of VIM-4 Metallo-β-Lactamase-Producing Pseudomonas sp. Isolates in Hungary

Published:2006-12 Issue:12 Volume:50 Page:4220-4223
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Libisch Balázs¹,Muzslay Mónika²,Gacs Mária¹,Minárovits János³,Knausz Márta⁴,Watine Joseph⁵,Ternák Gábor⁶,Kenéz Éva⁷,Kustos Ildikó⁸,Rókusz László⁹,Széles Klára¹⁰,Balogh Boglárka¹,Füzi Miklós¹

Affiliation:

1. Department of Bacteriology, National Center for Epidemiology, 1097 Budapest, Hungary

2. Department of Molecular Epidemiology, National Center for Epidemiology, 1097 Budapest, Hungary

3. Microbiological Research Group, National Center for Epidemiology, 1529 Budapest, Hungary

4. Aladár Petz County Teaching Hospital, 9023 Győr, Hungary

5. Laboratoire de Biologie Polyvalente, Hôpital Général, 12027 Rodez Cédex 9, France

6. Department of Infectious Diseases, Baranya County Hospital, 7623 Pécs, Hungary

7. Laboratory of Microbiology, Baranya County Hospital, 7623 Pécs, Hungary

8. Department of Medical Microbiology and Immunology, University of Pécs, 7643 Pécs, Hungary

9. Department of Internal Medicine, Central Military Hospital, 1553 Budapest, Hungary

10. Department of Epidemiology, National Public Health Service, 9024 Győr, Hungary

Abstract

ABSTRACT VIM metallo-β-lactamase-producing serotype O11 or O12 Pseudomonas aeruginosa isolates infecting or colonizing 19 patients from seven hospitals in Hungary were characterized between October 2003 and November 2005. Macrorestriction analysis revealed the involvement of hospitals from three different towns in northwest Hungary in an outbreak caused by VIM-4-producing P. aeruginosa .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00300-06

Reference23 articles.

1. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Clinical and Laboratory Standards Institute Wayne Pa.

2. Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-8, a Novel Metallo-β-Lactamase, in a Tertiary Care Center in Cali, Colombia

3. Molecular Epidemiology of Acquired-Metallo-β-Lactamase-Producing Bacteria in Poland

4. Grattard, F., O. G. Gaudin, B. Pozzeto, A. Ris, and A. D. Mbida. 1993. Genotypic homogeneity of nosocomial Pseudomonas aeruginosa O12 strains demonstrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns. Eur. J. Clin. Microbiol. Infect. Dis.12:57-61.

5. Johan Béla National Public Health Institute. 1997. Antibiotic susceptibility of the most important gram-negative bacteria, p. 159-173. In The 1996 annual report of the Johan Béla National Public Health Institute. Johan Béla National Public Health Institute, Budapest, Hungary. (In Hungarian.)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Based Epidemiologic Analysis of VIM/IMP Carbapenemase-Producing Enterobacter spp., Poland;Emerging Infectious Diseases;2023-08

2. Escherichia coli ST471 Producing VIM-4 Metallo-β-Lactamase in Colombia;Microbial Drug Resistance;2022-01-04

3. Pseudomonas aeruginosa;Molecular Typing in Bacterial Infections, Volume II;2022

4. Expression of AraC/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes;Journal of Antimicrobial Chemotherapy;2020-01-20

5. First Italian outbreak of VIM-producingSerratia marcescensin an adult polyvalent intensive care unit, August-October 2018: A case report and literature review;World Journal of Clinical Cases;2019-11-06